Seeded assembly in vitro does not replicate the structures of α‐synuclein filaments from multiple system atrophy

The propagation of conformational strains by templated seeding is central to the prion concept. Seeded assembly of α‐synuclein into filaments is believed to underlie the prion‐like spreading of protein inclusions in a number of human neurodegenerative diseases, including Parkinson's disease, dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). We previously determined the atomic structures of α‐synuclein filaments from the putamen of five individuals with MSA. Here, we used filament preparations from three of these brains for the in vitro seeded assembly of recombinant human α‐synuclein. We find that the structures of the seeded assemblies differ from those of the seeds, suggesting that additional, as yet unknown, factors play a role in the propagation of the seeds. Identification of these factors will be essential for understanding the prion‐like spreading of α‐synuclein proteinopathies.

[1]  M. Goedert,et al.  Cryo-EM structures of tau filaments. , 2020, Current opinion in structural biology.

[2]  Sarah Holec,et al.  Evidence of distinct α-synuclein strains underlying disease heterogeneity , 2020, Acta Neuropathologica.

[3]  B. Giasson,et al.  The emerging role of α-synuclein truncation in aggregation and disease , 2020, The Journal of Biological Chemistry.

[4]  Dan Li,et al.  Parkinson’s disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM , 2020, Proceedings of the National Academy of Sciences.

[5]  D. Dickson,et al.  α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species , 2020, The Journal of Biological Chemistry.

[6]  H. Stahlberg,et al.  New insights on the structure of alpha-synuclein fibrils using cryo-electron microscopy , 2020, Current Opinion in Neurobiology.

[7]  Sjors H W Scheres,et al.  Estimation of high-order aberrations and anisotropic magnification from cryo-EM data sets in RELION-3.1 , 2020, IUCrJ.

[8]  A. Murzin,et al.  Structures of α-synuclein filaments from multiple system atrophy , 2020, Nature.

[9]  K. Nilsson,et al.  Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy , 2020, Nature.

[10]  D. Eisenberg,et al.  The α-synuclein hereditary mutation E46K unlocks a more stable, pathogenic fibril structure , 2019, Proceedings of the National Academy of Sciences.

[11]  R. Riek,et al.  Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy , 2019, eLife.

[12]  G. Halliday,et al.  Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts , 2019, Nature Communications.

[13]  Sjors H.W. Scheres,et al.  Amyloid structure determination in RELION-3.1 , 2019, bioRxiv.

[14]  B. Ghetti,et al.  Silver staining (Campbell-Switzer) of neuronal α-synuclein assemblies induced by multiple system atrophy and Parkinson’s disease brain extracts in transgenic mice , 2019, Acta Neuropathologica Communications.

[15]  D. Eisenberg,et al.  Cryo-EM structures of α-synuclein fibrils with the H50Q hereditary mutation reveal new polymorphs , 2019, bioRxiv.

[16]  Alexey G. Murzin,et al.  Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules , 2019, Nature.

[17]  A. Murzin,et al.  Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases , 2018, bioRxiv.

[18]  Erik Lindahl,et al.  New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.

[19]  M. Hasegawa,et al.  Potent prion-like behaviors of pathogenic α-synuclein and evaluation of inactivation methods , 2018, Acta Neuropathologica Communications.

[20]  Tristan Ian Croll,et al.  ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.

[21]  John L. Robinson,et al.  Cellular Milieu Imparts Distinct Pathological α-Synuclein Strains in α-Synucleinopathies , 2018, Nature.

[22]  R. Riek,et al.  Cryo-EM structure of alpha-synuclein fibrils , 2018, bioRxiv.

[23]  S. Prusiner,et al.  Familial Parkinson’s point mutation abolishes multiple system atrophy prion replication , 2017, Proceedings of the National Academy of Sciences.

[24]  D. Eisenberg,et al.  Propagation of Tau Aggregates and Neurodegeneration. , 2017, Annual review of neuroscience.

[25]  A. Murzin,et al.  Cryo-EM structures of Tau filaments from Alzheimer’s disease brain , 2017, Nature.

[26]  Zhefeng Guo,et al.  Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation , 2017, Royal Society Open Science.

[27]  Sjors H.W. Scheres,et al.  Helical reconstruction in RELION , 2016, bioRxiv.

[28]  G. Petsko,et al.  Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy , 2016, Proceedings of the National Academy of Sciences.

[29]  H. Akiyama,et al.  The Effect of Fragmented Pathogenic α-Synuclein Seeds on Prion-like Propagation* , 2016, The Journal of Biological Chemistry.

[30]  Alexander K. Buell,et al.  Chemical properties of lipids strongly affect the kinetics of the membrane-induced aggregation of α-synuclein , 2016, Proceedings of the National Academy of Sciences.

[31]  N. Grigorieff,et al.  CTFFIND4: Fast and accurate defocus estimation from electron micrographs , 2015, bioRxiv.

[32]  Nicholas K. Sauter,et al.  Structure of the toxic core of α-synuclein from invisible crystals , 2015, Nature.

[33]  T. Südhof,et al.  Propagation of prions causing synucleinopathies in cultured cells , 2015, Proceedings of the National Academy of Sciences.

[34]  Michel Goedert,et al.  Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein , 2015, Science.

[35]  Chuong B. Do,et al.  Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease , 2014, Nature Genetics.

[36]  Michele Vendruscolo,et al.  Solution conditions determine the relative importance of nucleation and growth processes in α-synuclein aggregation , 2014, Proceedings of the National Academy of Sciences.

[37]  Markus Tolnay,et al.  The propagation of prion-like protein inclusions in neurodegenerative diseases , 2010, Trends in Neurosciences.

[38]  Charles Weissmann,et al.  Darwinian Evolution of Prions in Cell Culture , 2010, Science.

[39]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[40]  J. Trojanowski,et al.  Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells , 2009, Proceedings of the National Academy of Sciences.

[41]  Bjarni V. Halldórsson,et al.  Large-scale Meta-analysis of Genome-wide Association (GWA) Scans for Osteoporosis Traits: the GEFOS Consortium , 2008 .

[42]  Henning Stahlberg,et al.  The fold of α-synuclein fibrils , 2008, Proceedings of the National Academy of Sciences.

[43]  R. Hauser,et al.  Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease , 2008, Nature Medicine.

[44]  Elisabet Englund,et al.  Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation , 2008, Nature Medicine.

[45]  John Collinge,et al.  A General Model of Prion Strains and Their Pathogenicity , 2007, Science.

[46]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[47]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[48]  Janel O. Johnson,et al.  α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.

[49]  H. Braak,et al.  Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.

[50]  T. Iwatsubo,et al.  Biochemical Characterization of the Core Structure of α-Synuclein Filaments* , 2002, The Journal of Biological Chemistry.

[51]  J. Trojanowski,et al.  Neuronal α-Synucleinopathy with Severe Movement Disorder in Mice Expressing A53T Human α-Synuclein , 2002, Neuron.

[52]  E. Masliah,et al.  alpha-Synuclein is phosphorylated in synucleinopathy lesions. , 2002, Nature cell biology.

[53]  L. Serpell,et al.  Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Peter T. Lansbury,et al.  Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease , 1998, Nature Medicine.

[55]  R. Anthony Crowther,et al.  Synthetic filaments assembled from C‐terminally truncated α‐synuclein , 1998 .

[56]  R. Crowther,et al.  α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .

[57]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[58]  B. McEwen,et al.  Alzheimer's and Parkinson's Diseases: Mechanisms, Clinical Strategies, and Promising Treatments of Neurodegenerative Diseases 11th International Conference AD/PDTM Florence, Italy, March 6-10, 2013: Abstracts , 2013, Neurodegenerative Diseases.

[59]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[60]  S. Prusiner.  Novel proteinaceous infectious particles cause scrapie. , 1982, Science.